Atlas Trials

Response to PARP Inhibitor Predicted by the RAD51 Assay

Clinical trial NCT03044795 · WITHDRAWN

Trial details

NCT number
NCT03044795
Sponsor
University Medical Center Groningen
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Cancer
Start date
2019-11-01
Primary completion
2020-11-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.